Isomorphic Labs is a digital biology company, a subsidiary of Alphabet, launched in 2021. Its mission is to use AI and machine learning to accelerate and improve the drug discovery process. Building on groundbreaking research from DeepMind, particularly AlphaFold, Isomorphic Labs aims to model and understand fundamental mechanisms of life to find cures for some of humanity’s most devastating diseases. They focus on applying AI to the entire end-to-end drug discovery process, from predicting protein structures to designing novel therapeutics.
Primary center for research and development, AI model creation, computational biology, and strategic operations.
Located in King's Cross, a vibrant tech and innovation district, likely within or near Google's UK headquarters, offering state-of-the-art facilities and collaborative spaces.
A highly innovative, research-intensive, and mission-driven environment, fostering collaboration between AI experts, biologists, chemists, and engineers. Emphasis on scientific rigor and breakthroughs.
The London HQ is central to Isomorphic Labs' strategy, leveraging the UK's strong talent pool in AI and life sciences, and its proximity to academic institutions and DeepMind.
Isomorphic Labs primarily operates from its headquarters in London, UK, with a growing presence in Lausanne, Switzerland, to support European collaborations. While its physical offices are concentrated, its research collaborations and partnerships with pharmaceutical giants like Eli Lilly (US) and Novartis (Switzerland) give it a global reach in terms of impact and operations. Its technology aims to address global health challenges, and its talent pool is sourced internationally.
6 Pancras Square
London
England
United Kingdom
Address: EPFL Innovation Park, Building C, 1015 Lausanne, Switzerland (Exact address may vary, this is a common tech hub location)
Strengthening presence in continental Europe, facilitating direct engagement with European partners, and tapping into Switzerland's strong pharmaceutical research environment.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Isomorphic Labs' leadership includes:
Isomorphic Labs has been backed by several prominent investors over the years, including:
Isomorphic Labs has been building its core leadership team. In the past year, key strategic hires have bolstered its scientific and operational capabilities. No major high-profile executive departures have been publicly announced.
Discover the tools Isomorphic Labs uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Isomorphic Labs, as an Alphabet company, likely follows common corporate email patterns. The most probable formats include first name initial followed by last name, or first name separated from last name by a dot.
[first_initial][last]@isomorphiclabs.com or [first].[last]@isomorphiclabs.com
Format
jdoe@isomorphiclabs.com or jane.doe@isomorphiclabs.com
Example
85%
Success rate
Isomorphic Labs Blog • January 8, 2024
Isomorphic Labs and Novartis entered a strategic multi-target research collaboration to discover small molecule therapeutics against three undisclosed targets. Isomorphic Labs will receive a $37.5 million upfront payment and is eligible for performance-based milestone payments up to $1.2 billion, plus royalties....more
Isomorphic Labs Blog • January 5, 2024
Isomorphic Labs partnered with Eli Lilly to discover small molecule therapeutics against multiple undisclosed targets. Isomorphic will receive $45 million upfront, with potential for up to $1.7 billion in performance-based milestones, plus royalties....more
DeepMind Blog (via Isomorphic Labs) • November 4, 2021
Alphabet announced the launch of Isomorphic Labs, a new company that aims to use AI to accelerate drug discovery, building on research from DeepMind. Demis Hassabis is the Founder and acting CEO....more
Isomorphic Labs Blog • July 19, 2023
Isomorphic Labs announced new additions to its leadership team: Dr. Aris Baras as VP, Head of Translational Medicine; Dr. Sotirios Stergiopoulos as VP, Head of Quantitative & Computational Biology; and Dr. John Pasi as Clinical Advisor. These appointments aim to strengthen the company's capabilities in bringing AI-discovered medicines to patients....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Isomorphic Labs, are just a search away.